-
Mashup Score: 2A single dose of HPV vaccine may provide adequate protection | Frederick National Laboratory - 10 month(s) ago
A growing body of evidence suggests that a single dose of vaccine against cancer-causing human papilloma virus (HPV) may protect as well as the standard two-or-more dose regimen. This would make it easier to protect more women, especially in low-income areas where vaccine access is scarce.
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2RAS Initiative | Frederick National Laboratory - 11 month(s) ago
Image
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Experimental flu vaccine shows protection against many strains | Frederick National Laboratory - 1 year(s) ago
A research group including Frederick National Laboratory scientists has taken an early step toward a universal influenza vaccine that appears to protect against many strains, including the closely watched H5N1 bird flu. Human trials are under way. Conventional seasonal flu vaccines target the rapidly mutating head of the hemagglutinin (HA) protein on the virus particle, so the vaccine must be…
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Frederick National Laboratory produces CAR T-cell immunotherapies for pediatric cancer clinical trials | Frederick National Laboratory - 1 year(s) ago
Image
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6Real-world studies indicate NSAIDs improve lung cancer survival | Frederick National Laboratory - 1 year(s) ago
Common drugs for controlling pain and inflammation â such as aspirin and ibuprofen â improved overall lung cancer survival by a statistically significant margin in a long-term study of patient medical records. This finding called for more definitive randomized clinical trials.
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A study of patient medical records has found a link between common drugs for controlling pain and inflammation â such as aspirin and ibuprofen â and survival in lung cancer. This finding called for more definitive randomized clinical trials. https://t.co/QlxBdID0IO #LCAM đ« https://t.co/bvx11qwWRk
-
-
Mashup Score: 8Second HIV patient appears to have cured herself with natural immunity | Frederick National Laboratory - 2 year(s) ago
Frederick National Laboratory scientists were part of a multi-institutional collaboration that has identified a second patient whose natural immune response to HIV infection appears to have cured her of the disease, raising the question: Can this be replicated?
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Scientists have identified a second patient whose natural immunity cured herself of detectable #HIV. The 30-year-old woman from Argentina, who tested positive in 2013, received antiretroviral drugs for 6 months, and has since been free of detectable virus. https://t.co/0gp1DACyJY https://t.co/nE4xxVuUAG
-
-
Mashup Score: 8
Five new projects led by Frederick National Laboratory for Cancer Research (FNL) scientists have earned Laboratory Directed Exploratory Research (LDER) funding for the upcoming fiscal year.
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7July 2022 | Frederick National Laboratory - 2 year(s) ago
The scientific community has collaborated extensively in response to the coronavirus pandemic. Research has begun to reveal a clearer picture of vaccination, immunity, and COVID-19 in cancer patients and other immunocompromised people, while other studies have sought to understand immunity after infection. Meanwhile, vaccines and vaccine research offer hope toward ending the pandemic, but vaccine…
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6AIDS and Cancer Virus Program | Frederick National Laboratory - 2 year(s) ago
The AIDS and Cancer Virus Program works to improve the prevention, diagnosis, and treatment of HIV infection and AIDS-related tumors through basic, applied, and translational research, including development and sharing of novel experimental models, reagents and analytical methods. Through investigator-driven research and extensive collaborations between our research sections and research support…
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7Cancer researchers invited to apply for new cryo-EM training program | Frederick National Laboratory - 2 year(s) ago
The Frederick National Laboratory will host a new training program in Frederick, Maryland, September 12-16 for cancer researchers who want to build expertise in c
Source: Frederick National LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
A growing body of evidence suggests that a single dose of vaccine against cancer-causing human papillomavirus (HPV) may protect as well as the standard two-or-more dose regimen. Learn more: https://t.co/WDnvuKH3qq #HPV @FredNatLab